Down syndrome does shorten lifespan, but far less than it once did. The current life expectancy for a person born with Down syndrome is roughly 55 to 60 years, depending on the study and population. That number has climbed dramatically over the past several decades, rising from a median age at death of just 1 year in 1968 to 49 years by 1997, and continuing upward since. Still, a significant gap remains compared to the general population.
How Life Expectancy Has Changed Over Time
The improvement in Down syndrome life expectancy is one of the most striking shifts in modern medicine. In 1950, a baby born with Down syndrome in the U.S. had a median life expectancy of roughly four years. By 1960, the average had risen to about 10 years. By 2007, it reached 47 years. Recent estimates from KFF Health News and Harvard-affiliated researchers place it at around 58 years as of the 2010s, and an Australian cohort study published in BMJ Open found a life expectancy at birth of about 55 years for individuals born in 2018.
The reasons behind this jump are largely practical. Before the 1960s, people with disabilities were routinely institutionalized and sometimes denied basic medical care, including surgeries to correct life-threatening birth defects. As disability rights movements gained traction, courts made it illegal to withhold treatment, and medical ethics evolved, children with Down syndrome began receiving the same cardiac surgeries, antibiotics, and hospital care as anyone else. That single shift, treating treatable conditions, accounts for most of the survival gains.
In 1950, fewer than 50,000 Americans were living with Down syndrome. By 2017, that number topped 217,000, including tens of thousands of people in middle age and beyond.
The Biggest Health Threats
Data from U.S. death records between 2013 and 2017 reveal what adults with Down syndrome most commonly die from. Dementia and Alzheimer’s disease top the list at nearly 21% of deaths, followed by heart disease at about 13%, and pneumonia or influenza at roughly 12%. Aspiration pneumonia (caused by food or liquid entering the lungs) accounts for another 10%, and choking-related deaths are notably more common at every age compared to the general population.
This pattern looks quite different from the leading causes of death in the general population. Cancer, which is the second-leading killer in the broader U.S., accounts for only about 2% of deaths among adults with Down syndrome. Meanwhile, respiratory problems and swallowing difficulties remain persistent risks throughout life, not just in old age.
Congenital Heart Defects
Up to 56% of babies born with Down syndrome have some form of congenital heart defect, most commonly holes between the chambers of the heart. These defects can cause blood to flow abnormally into the lungs, raising pressure in the pulmonary arteries. Before routine surgical repair became standard, these heart conditions were a leading cause of death in infancy. Today, most can be corrected in the first year of life, and babies who survive that surgery generally do well long-term. However, babies born with both a very low birth weight and a heart defect still face higher risk of not surviving their first year.
Alzheimer’s Disease
The connection between Down syndrome and Alzheimer’s is strong and begins early. The extra copy of chromosome 21 that causes Down syndrome also carries the gene responsible for producing amyloid precursor protein, the substance that builds up in the brains of people with Alzheimer’s. As a result, between 23% and 55% of people with Down syndrome show signs of Alzheimer’s by their 40s. By their 60s, the figure rises to 75% to 88%. The average age of Alzheimer’s diagnosis in this population is about 54, which is roughly 20 years earlier than in the general population. Because Alzheimer’s is the single leading cause of death in adults with Down syndrome, this early onset plays a major role in limiting lifespan.
Sleep Apnea and Respiratory Problems
Obstructive sleep apnea is nearly universal among adults with Down syndrome, and it tends to be more severe. Studies estimate the childhood prevalence at 50% to 100%, with rates approaching 100% in adulthood. The physical features that contribute to this include a smaller airway, a relatively large tongue, and lower muscle tone in the throat. Left untreated, sleep apnea places chronic stress on the heart and lungs. In people who already have congenital heart disease, this combination raises the risk of pulmonary hypertension, a condition where blood pressure in the lungs becomes dangerously high. Treatment of sleep apnea, typically with a CPAP machine or in some cases surgery, has been shown to improve or even resolve pulmonary hypertension in this group.
Childhood Leukemia Risk
Children with Down syndrome face an elevated risk of two types of blood cancer: acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). The outcomes are somewhat counterintuitive. Children with Down syndrome who develop AML actually fare better than other children with the same cancer subtype, with about 80% surviving five years compared to 35% without Down syndrome. But the picture reverses for ALL: about 70% of children with Down syndrome survive, compared to roughly 90% of children without it. Treatment also tends to be harder on their bodies, with higher rates of infection, mouth sores, and prolonged hospital stays.
Racial Disparities in Survival
Down syndrome occurs at roughly the same rate across all racial groups, about one in every 800 live births. But survival outcomes are not equal. CDC data tracking deaths from 1968 through 1997 found that the median age at death for white Americans with Down syndrome rose from 2 years to 50 years over that period. For Black Americans with Down syndrome, the median rose from 0 to just 25 years. That gap has narrowed somewhat since, but more recent CDC data still notes that Black infants with Down syndrome have lower survival past the first year, and the reasons are not fully understood. The proportion of heart defects listed on death certificates was similar across racial groups, suggesting the disparity stems from differences in access to care and socioeconomic factors rather than biology.
What Makes the Biggest Difference
The single most impactful factor in the dramatic increase in lifespan has been access to standard medical care, particularly heart surgery in infancy. Beyond that first year, the factors that matter most for long-term survival include managing sleep apnea (which affects cardiovascular health over decades), monitoring for early signs of cognitive decline in the 40s, and paying attention to swallowing safety, since aspiration and choking remain underappreciated risks at every age.
The gap between Down syndrome life expectancy and the general population’s is still roughly 20 to 25 years. But the trajectory over the past 70 years has been remarkable. A condition that once meant a life expectancy of four years now routinely allows people to reach their 50s and 60s, and the generation aging into middle adulthood today is the first to do so in large numbers. The healthcare system is still catching up to that reality, with many adults finding that services are structured around children and that providers have limited experience managing Down syndrome in older adults.